Effects of acute exercise on fibrinolysis and coagulation in patients with coronary artery disease

International Heart Journal

Volumn 48, Issue 3, 2007, Pages 277-285

  Acil, Tayfun ^a,b   Atalar, Enver ^a   Sahiner, Levent ^a   Kaya, Baris ^a   Haznedaroglu, Ibrahim C ^a   Tokgozoglu, Lale ^a   Ovunc, Kenan ^a   Aytemir, Kudret ^a   Ozer, Necla ^a   Oto, Ali ^a   Ozmen, Ferhan ^a   Nazli, Nasih ^a   Kes, Sirri ^a   Aksoyek, Sedar ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Coagulation; Coronary artery disease; Exercise

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; NITRATE; PROTHROMBIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; FEMALE; FIBRINOLYSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; TREADMILL EXERCISE;

AGGLUTINATION TESTS; BLOOD COAGULATION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FIBRINOLYSIS; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROGNOSIS; PROTHROMBIN; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 34547509731     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.277     Document Type: Article

References (24)

1. Tofler GH. Triggering and the pathophysiology of acute coronary syndromes. Am Heart J 1997; 134: S55-61. (Review)
2. El-Sayed MS, Sale C, Jones PG, Chester M. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32: 918-25. (Review)
3. Drygas WK, Rodier L, Boldt F, Heyduck B, Altenkirch HU. The hemostatic and fibrinolytic system in normal subjects and myocardial infarct patients. Effect of a standardized aerobic and anaerobic ergometric stress test. Dtsch Med Wochenschr 1987; 112: 995-9.
4. Estelles A, Tormo G, Aznar J, Espana F, Tormo V. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thromb Res 1985; 40: 373-83.
5. Lins M, Arendt T, Deutschmann A, Dieszbrock O, Steen U, Bruhn HD. Effect of exercise tolerance test on hemostasis in patients with and without coronary heart disease. Med Klin (Munich) 2000; 95: 14-9. (German)
6. De Scalzi M, Rafanelli D, de Leonardis V, et al. Does ergometric stress test induce a procoagulative condition in patients with previous myocardial infarction? Clin Cardiol 1989; 12: 255-8.
7. Hamouratidis ND, Pertsinidis TE, Bacharoudis GP, Papazachariou GS. Effects of exercise on plasma fibrinolytic activity in patients with ischaemic heart disease. Int J Cardiol 1988; 19: 39-45.
8. Rydzewski A, Sakata K, Kobayashi A, et al. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Haemostasis 1990; 20: 305-12.
9. Amiral J. The global fibrinolytic capacity. Fibrinolysis 1996; 10 (Suppl3): 95.
10. Yurdakok M, Yigit S, Korkmaz A, Kirazli S, Aygun C. Global fibrinolytic capacity in healthy newborn infants. Turk J Pediatr 2001; 43: 177-9.
11. Ozatli D, Sayinalp N, Buyukasik Y, et al. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behcet's disease: evidence of a prethrombotic state. Rheumatol Int 2002; 21: 137-40.
12. Atalar E, Acil T, Aytemir K, et al. Diminished global fibrinolytic capacity in patients with mitral valve prolapse is associated with transient ischemic attacks. Clin Appl Thromb Hemost 2002; 8: 41-4.
13. Atalar E, Ozmen F, Haznedaroglu I, et al. Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease. Int J Cardiol 2002; 84: 227-31.
14. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-9.
15. Bruce RA. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res 1971; 3: 323-32.
16. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998; 19: C39-43. (Review)
17. Ernst E, Koenig W. Fibrinogen and cardiovascular risk. Vasc Med 1997; 2: 115-25. (Review)
18. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-9.
19. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting fictors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
20. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation 1996; 94: 2057-63.
21. Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 1995; 27: 1465-70.
22. Ferguson EW, Bair CF, Bernier LL. Fibrinogenolysis and fibrinolysis with strenuous exercise. J Appl Physiol 1979; 47: 1157-61.
23. Hansen JB, Wilsgard L, Olsen JO, Osterud B. Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenous physical exercise. Thromb Haemost 1990; 64: 385-9.
24. Lin X, El-Sayed MS, Waterhouse J, Reilly T. Activation and disturbance of blood haemostasis following strenuous physical exercise. Int J Sports Med 1999; 20: 149-53.